Tuesday, March 17, 2026

(G)I-DLE to Appear on NBC’s ‘The Kelly Clarkson Show’ as U.S. Promotions Accelerate

K-pop group (G)I-DLE will debut on NBC's "The Kelly Clarkson Show" on June 13, performing their single "Mono" and promoting their tour.

Is Your Pup Acting Weird? It Could Be More Than Just a Phase

Even if dogs have joint conditions like patellar luxation or cruciate ligament rupture, they may appear to live normally.

Samsung’s Latest Tech Marvels Unveiled in Paris

Samsung Electronics' Galaxy Unpacked Day has arrived....

Tag: market

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

Korean Medical AI Lands at the University of Washington: Neurofit Signs U.S. Deal for Brain MRI + PET Analysis Tools

Neurofit signs a contract to supply AI medical solutions to the University of Washington, marking its U.S. market entry and expansion.

Celltrion’s Remsima Surpasses 1 Trillion KRW in Sales for 2nd Consecutive Year: What’s Driving Its Success?

Celltrion's Remsima treatment surpasses 1 trillion KRW in sales, driven by European market growth and new liquid formulation.

Hyundai Motor Group Sweeps U.S. Media Awards: 17 Models Win Car and Driver Editors’ Choice for 2026

Hyundai Motor Company shines in the U.S. with 17 awards from Car and Driver, showcasing its competitive models and innovations.

Celltrion Gets Global IB Upgrades: Morgan Stanley Raises Target to $206.25 as New Biosimilars Lift Margins

Celltrion is expanding through biosimilars and new drug development, attracting global investor interest and raising target stock prices.

How VIEWORKS’ VISQUE DPS is Transforming Digital Pathology in Europe: A Game Changer for Hospitals

Vieworks secures a European contract for its VISQUE DPS slide scanner, enhancing its global presence in digital pathology diagnostics.

Rokit Healthcare Secures UAE Patent for AI-Based Cartilage Regeneration: A Game-Changer in Middle Eastern Joint Treatment

Rokit Healthcare secures a UAE patent for AI cartilage regeneration, targeting a $682M market and shifting focus to regenerative medicine.

How LG CNS and FuriosaAI Are Revolutionizing AI Infrastructure for the Public Sector

LG CNS partners with FuriosaAI to enhance AI services using neural processing units, targeting the public AI transformation market.

How Celltrion’s Omlyclo is Dominating Spain’s Omalizumab Market: A First-Mover Success Story

Celltrion's Omlyclo treatment is thriving in Spain, capturing over 60% of the omalizumab market with innovative strategies and strong demand.

GC Biopharma Corp Soars After Eight Years on the Back of Immunodeficiency Drug Alyglo, Posting Results in U.S. Market Push

GC Biopharma Corp breaks its fourth-quarter deficit with ALYGLO's success, achieving $106M in annual revenue and plans for future growth.

Celltrion’s Remsima SC: The Leading Autoimmune Drug with 68% Market Share in Europe

Celltrion's treatments for autoimmune diseases and cancer maintain strong market positions in Europe, bolstered by stable prescriptions and new products.

Celltrion’s Zymfentra: How This Breakthrough Drug is Driving Record Sales

Celltrion expects record sales driven by Zymfentra's success, expanding into new biosimilars and CDMO business for future growth.

Volkswagen’s Audi Factory Plans: Will U.S. Tariff Changes Decide Their Fate?

Volkswagen's U.S. factory plans depend on tariff reductions; CEO Blume cites significant costs from past tariffs and calls for stable conditions.

How EverEx’s AI Solutions Are Transforming Musculoskeletal Care in the U.S. Market

EverEx is revolutionizing remote therapy monitoring in the U.S. with AI technology, aiming for a fivefold sales increase this year.

Unlock Youthful Skin: A Comprehensive Guide to Elabie Premier Fillers Launched in Thailand

Humedics launches Elavie Premier HA fillers in Thailand, marking significant expansion in Southeast Asia with a successful symposium.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.